“Uber for nurses” is extracting profits and hurting health care, all to solve a problem that doesn’t exist.
Health Care
The country’s largest insurers spent $120 billion on stock buybacks since 2010, with nearly half of that spent by UnitedHealth.
Since the Affordable Care Act’s passage, the top five health insurers’ annual profits have jumped 230 percent, with much of that going to UnitedHealthcare.
In the heart of the state that could decide the election, people are grappling with a crisis largely ignored by both Trump and Harris.
The University of California has raked in a previously undisclosed $1.6 billion from Xtandi sales, and now doesn’t want the government lowering exorbitant drug costs.
The pharma giant previously received billions in federal funding and raked in huge profits, but owes nothing in 2023 income taxes thanks to legal loopholes and Trump-era tax cuts.
While industry leaders plead poverty to fight a proposed staffing standard, private equity owners are funneling cash into their affiliated real estate and management firms.
Why are generic drugmakers fighting a plan to let them make more medicines?
Right-wing federal appeal judges signal they support repeal of the no-cost preventive care mandate, all but guaranteeing a Supreme Court showdown.
As the first-ever Medicare drug-price negotiations take shape, Big Pharma-backed Democrats want to limit the number of costly medicines regulators can target.